Drug Type Small molecule drug |
Synonyms- |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists), D4 receptor antagonists(Dopamine D4 receptor antagonists), miR-34a agonists(microRNA 34a agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H12F2N2O2 |
InChIKeyVJPSLCIXPMZKDH-UHFFFAOYSA-N |
CAS Registry1468402-86-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | CN | 26 Sep 2019 |